Today's Top Stories


Hot Topics


Comment & Analysis »

GlobalData Healthcare

FOURIER outcomes data highlights the importance of value in drug development

Highly anticipated results from the FOURIER trial of Amgen’s Repatha (evolocumab) were presented at the American College of Cardiology (ACC) late breaking clinical trial session held in...

FOURIER outcomes data highlights the importance of value in drug development
GlobalData Healthcare

Unmet needs in the liver cancer market mean it’s full of potential

Unmet needs in the liver cancer market mean it’s full of potential
GlobalData Healthcare

First-in-class opioid analgesic NKTR-181 boasts strong Phase III results

First-in-class opioid analgesic NKTR-181 boasts strong Phase III results
GlobalData Healthcare

Amgen and Cytokinetics: approaching acute heart failure from a different angle

Amgen and Cytokinetics: approaching acute heart failure from a different angle
GlobalData Healthcare

New class of diabetes drugs show heart failure prevention signal

New class of diabetes drugs show heart failure prevention signal

Company Releases »

Evaluating API and Excipient Characteristics for Tablet Formulations

Gamlen Instruments
Evaluating API and Excipient Characteristics for Tablet Formulations

Improving OMNISEC Results by Switching Mobile Phases

Malvern Instruments
Improving OMNISEC Results by Switching Mobile Phases

Benefits of Trehalose

Pfanstiehl Benefits of Trehalose

ePAT Automated Lab Reactor Optimised for 24/7 Data Capture

SYSTAG Systems Technik
ePAT Automated Lab Reactor Optimised for 24/7 Data Capture

Analysing Polysaccharides Using OMNISEC

Malvern Instruments Analysing Polysaccharides Using OMNISEC

Drugdevelopment Insights »

Drugdevelopment Industry Reports »

Recent failures in Alzheimer’s R&D

Recent failures in Alzheimer’s R&D

Report: Immune thrombocytopenia market to witness minimal growth at CAGR of 0.6% by 2025

Report: Immune thrombocytopenia market to witness minimal growth at CAGR of 0.6% by 2025

Total Prevalent Cases of Dyslipidemia Expected to Grow Globally

Total Prevalent Cases of Dyslipidemia Expected to Grow Globally

Report: Rheumatoid arthritis market projected to reach $28.5bn by 2025

Report: Rheumatoid arthritis market projected to reach $28.5bn by 2025








cachename:HomePagecachekey:rd-1665407042_1729060782_rd-488908060_1460672566_ap1460672566_1729060782_1903286115